Trials / Active Not Recruiting
Active Not RecruitingNCT06714461
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
Post Authorization Safety Study on Assessment of Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,500 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The main objective of this post-authorization safety study is to assess healthcare professionals' awareness, knowledge, and behavior related to receipt and reading of the Direct Healthcare Professional Communication and educational materials for ARAVA® (leflunomide) and of the additional risk minimization measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Leflunomide | This study will not administer any treatment, only observe the treatment as prescribed in real-world clinical practices. |
Timeline
- Start date
- 2025-05-05
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
- First posted
- 2024-12-03
- Last updated
- 2026-03-09
Locations
1 site across 1 country: France
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06714461. Inclusion in this directory is not an endorsement.